TruTag Technologies, Inc., a Skai Ventures portfolio company, developer of a covert security platform to address the global product counterfeiting challenge, announced, April 01, 2014, that WuXi Corporate Venture Fund has made an investment in TruTag.
In addition, WuXi and TruTag will explore collaborations to offer WuXi’s global customers the TruTag on-dose authentication solution to help prevent counterfeiting and to enhance drug safety.
TruTag microtags (“TruTags®”) are inert and edible and can integrate into the fabric of a product without packaging or labels – much like fingerprints on a human being – for the authentication of food, drugs, electronics, consumer products, and industrial components.
WuXi PharmaTech is a pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. WuXi PharmaTech’s services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.